<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Methylenomycin_A</id>
	<title>Methylenomycin A - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Methylenomycin_A"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Methylenomycin_A&amp;action=history"/>
	<updated>2026-04-26T22:37:08Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Methylenomycin_A&amp;diff=5369500&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Methylenomycin_A&amp;diff=5369500&amp;oldid=prev"/>
		<updated>2024-03-06T06:44:56Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Methylenomycin A.svg|thumb|{{PAGENAME}}]]&amp;lt;br&amp;gt;&amp;#039;&amp;#039;&amp;#039;Methylenomycin A&amp;#039;&amp;#039;&amp;#039; is a [[macrolide]] [[antibiotic]] produced by the [[bacterium]] &amp;#039;&amp;#039;[[Streptomyces coelicolor]]&amp;#039;&amp;#039;. It is a member of the [[methylenomycin]] family of antibiotics, which are known for their broad-spectrum antibacterial activity.&lt;br /&gt;
&lt;br /&gt;
== Structure and Synthesis ==&lt;br /&gt;
&lt;br /&gt;
Methylenomycin A is a 16-membered macrolide antibiotic. Its structure is characterized by a large [[macrocyclic]] lactone ring, to which two [[deoxy sugar]] units are attached. The synthesis of Methylenomycin A involves a complex series of [[biochemical reactions]], including [[polyketide synthesis]], [[glycosylation]], and [[macrocyclization]].&lt;br /&gt;
&lt;br /&gt;
== Mechanism of Action ==&lt;br /&gt;
&lt;br /&gt;
Methylenomycin A exerts its antibacterial effect by inhibiting [[protein synthesis]] in susceptible bacteria. It binds to the [[50S ribosomal subunit]], preventing the [[translocation]] of [[peptidyl-tRNA]] from the A-site to the P-site on the [[ribosome]]. This results in the premature termination of protein synthesis, leading to bacterial cell death.&lt;br /&gt;
&lt;br /&gt;
== Clinical Use ==&lt;br /&gt;
&lt;br /&gt;
Methylenomycin A has been shown to be effective against a wide range of [[Gram-positive bacteria]], including &amp;#039;&amp;#039;[[Staphylococcus aureus]]&amp;#039;&amp;#039;, &amp;#039;&amp;#039;[[Streptococcus pneumoniae]]&amp;#039;&amp;#039;, and &amp;#039;&amp;#039;[[Enterococcus faecalis]]&amp;#039;&amp;#039;. However, its clinical use has been limited due to its poor [[bioavailability]] and potential for [[drug resistance]].&lt;br /&gt;
&lt;br /&gt;
== Research and Development ==&lt;br /&gt;
&lt;br /&gt;
Research into the biosynthesis and mechanism of action of Methylenomycin A has provided valuable insights into the biology of &amp;#039;&amp;#039;Streptomyces coelicolor&amp;#039;&amp;#039; and the general principles of antibiotic action. Furthermore, efforts are ongoing to engineer &amp;#039;&amp;#039;Streptomyces&amp;#039;&amp;#039; strains that can produce Methylenomycin A in higher yields, with the aim of developing a commercially viable production process.&lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
&lt;br /&gt;
* [[Methylenomycin B]]&lt;br /&gt;
* [[Macrolide]]&lt;br /&gt;
* [[Antibiotic resistance]]&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
{{reflist}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Antibiotics]]&lt;br /&gt;
[[Category:Macrolides]]&lt;br /&gt;
[[Category:Streptomyces]]&lt;br /&gt;
{{Antibiotics-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>